Download PDF
Thromb Haemost 2001; 85(03): 509-513
DOI: 10.1055/s-0037-1615613
Review Article
Schattauer GmbH

Contribution of Platelet-derived Factor Va to Thrombin Generation on Immobilized Collagen- and Fibrinogen-adherent Platelets

Jacob J. Briedé
1   Biochemistry, Human Biology
,
Johan W. M. Heemskerk
2   Biology and Surgery, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands
,
Veer Cornelis van’t
3   Surgery, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands
,
H. Coenraad Hemker
1   Biochemistry, Human Biology
,
Theo Lindhout
1   Biochemistry, Human Biology
› Author Affiliations
Further Information

Publication History

Received 19 April 2000

Accepted after resubmission 30 October 2000

Publication Date:
27 December 2017 (online)

    Permissions and Reprints

Summary

Adhesion of platelets to immobilized collagen induces the expression of anionic phospholipids, e. g. phosphatidylserine (PS), in the outer leaflet of the plasma membrane of these platelets. In contrast, of the platelets that adhere to immobilized fibrinogen only a small sub-population representing 10 ± 3% of the total population of the fibrinogen-adherent platelets has exposed PS as probed by annexin V binding. Although the presence of PS is thought to be critical for thrombin generation at the platelet surface, no information is available about the effect of this differential PS exposure on the ability of adherent platelets to support thrombin generation. Perfusion of the fibrinogen- or collagen-adherent platelets with solutions containing factor Xa and prothrombin resulted in thrombin generation that i) increased linear during the first perfusion minutes, ii) was about two-fold faster at collagen-adherent than at fibrinogen-adherent platelets and iii) was for more than 98% restricted to the surface of the adherent platelets. It appeared that the lower thrombin generating capacity of fibrinogen-adherent platelets is not due to a lower overall surface density of PS, but is caused by lower amounts of platelet-bound factor Va. Firstly, in both cases thrombin generation could be completely attenuated with antibodies against human factor Va, and secondly, in the presence of an excess of exogenous plasma-derived factor Va similar initial rates of thrombin formation were measured for collagen- and fibrinogen-adherent platelets. Our findings suggest a unique role for immobilized collagen in maintaining haemostasis.

Keywords

Fibrinogen - collagen - platelets - platelet factor V - prothrombinase
 

  • References

  • 1 Sixma JJ, Hindriks G, Van Breugel H, Hantgan R, de Groot PG. Vessel wall proteins adhesive for platelets. J Biomater Sci Polym 1991; 3: 17-26.
    PubMedGoogle Scholar
  • 2 Nesheim ME, Taswell JB, Mann KG. The contribution of bovine Factor V and Factor Va to the activity of prothrombinase. J Biol Chem 1979; 254: 10952-62.
    PubMedGoogle Scholar
  • 3 Rosing J, Tans G, Govers Riemslag JW, Zwaal RFA, Hemker HC. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980; 255: 274-83.
    PubMedGoogle Scholar
  • 4 Tracy PB, Eide LL, Bowie EJ, Mann KG. Radioimmunoassay of factor V in human plasma and platelets. Blood 1982; 60: 59-63.
    PubMedGoogle Scholar
  • 5 Baruch D, Hemker HC, Lindhout T. Kinetics of thrombin-induced release and activation of platelet factor V. Eur J. Biochem 1986; 154: 213-8.
    CrossrefPubMedGoogle Scholar
  • 6 Tracy PB, Giles AR, Mann KG, Eide LL, Hoogendoorn H, Rivard GE. Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet factor V deficiency. J Clin Invest 1984; 74: 1221-8.
    CrossrefPubMedGoogle Scholar
  • 7 Janeway CM, Rivard GE, Tracy PB, Mann KG. Factor V Quebec revisited. Blood 1996; 87: 3571-8.
    PubMedGoogle Scholar
  • 8 Nesheim ME, Nichols WL, Cole TL, Houston JG, Schenk RB, Mann KG, Bowie EJ. Isolation and study of an acquired inhibitor of human coagulation factor V. J Clin Invest 1986; 77: 405-15.
    CrossrefPubMedGoogle Scholar
  • 9 Bevers EM, Comfurius P, Zwaal RFA. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983; 736: 57-66.
    CrossrefPubMedGoogle Scholar
  • 10 Nesheim ME, Furmaniak Kazmierczak E, Henin C, Cote G. On the existence of platelet receptors for factor V(a) and factor VIII(a). Thromb Haemost 1993; 70: 80-6.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Bouchard BA, Catcher CS, Thrash BR, Adida C, Tracy PB. Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation. J Biol Chem 1997; 272: 9244-51.
    CrossrefPubMedGoogle Scholar
  • 12 Larson PJ, Camire RM, Wong D, Fasano NC, Monroe DM, Tracy PB, High KA. Structure/function analyses of recombinant variants of human factor Xa: Factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles. Biochemistry 1998; 37: 5029-38.
    CrossrefPubMedGoogle Scholar
  • 13 Byzova TV, Plow EF. Networking in the hemostatic system. Integrin αIIbβ3 binds prothrombin and influences its activation. J Biol Chem 1997; 272: 27183-8.
    CrossrefPubMedGoogle Scholar
  • 14 Heemskerk JWM, Vuist WMJ, Feijge MAH, Reutelingsperger CPM, Lind-hout T. Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine, and procoagulant activity of adherent platelets: Evidence for regulation by protein tyrosine kinase dependent Ca2+ responses. Blood 1997; 90: 2615-25.
    PubMedGoogle Scholar
  • 15 Billy D, Speijer H, Willems G, Hemker HC, Lindhout T. Prothrombin activation by prothrombinase in a tubular flow reactor. J Biol Chem 1995; 270: 1029-34.
    CrossrefPubMedGoogle Scholar
  • 16 Schoen P, Lindhout T, Franssen J, Hemker HC. Low molecular weight heparin-catalyzed inactivation of factor Xa and thrombin by antithrombin III: Effect of platelet factor 4. Thromb Haemost 1991; 66: 435-41.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Taylor FB, Hoogendoorn H, Chang AC, Peer G, Nesheim ME, Catlett R, Stump DC, Giles AR. Anticoagulant and fibrinolytic activities are promoted, not retarded, in vivo after thrombin generation in the presence of a monoclonal antibody that inhibits activation of protein C. Blood 1992; 79: 1720-8.
    PubMedGoogle Scholar
  • 18 Ambrosini GD, Altieri DC. Molecular dissection of effector cell protease receptor-1 recognition of factor Xa. Assignment of critical residues involved in antibody reactivity and ligand binding. J Biol Chem 1996; 271: 1243-8.
    CrossrefPubMedGoogle Scholar
  • 19 Billy D, Briede Heemskerk JWM, Hemker HC, Lindhout T. Prothrombin conversion under flow conditions by prothrombinase assembled on adherent platelets. Blood Coagul Fibrinolysis 1997; 8: 168-74.
    CrossrefPubMedGoogle Scholar
  • 20 Schoen P, Lindhout T, Willems G, Hemker HC. Continuous flow and the prothrombinase-catalyzed activation of prothrombin. Thromb Haemost 1990; 64: 542-7.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Briede JJ, Heemskerk JWM, Hemker HC, Lindhout T. Heterogeneity in microparticle formation and exposure of anionic phospholipids at the plasma membrane of single adherent platelets. Biochim Biophys Acta 1999; 1451: 163-72.
    CrossrefPubMedGoogle Scholar
  • 22 Hayward CP, Furmaniak Kazmierczak E, Cieutat AM, Moore JC, Bainton DF, Nesheim ME, Kelton JG, Cote G. Factor V is complexed with multi-merin in resting platelet lysates and colocalizes with multimerin in platelet alpha-granules. J Biol Chem 1995; 270: 19217-24.
    CrossrefPubMedGoogle Scholar
  • 23 Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL. Surface expression and functional characterization of alpha-granule factor V in human platelets: Effects of ionophore A23187, thrombin, collagen, and convulxin. Blood 2000; 95: 1694-702.
    CrossrefPubMedGoogle Scholar